CC-94676

· Celgene

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CC-94676, covering 2025-12-22 to 2025-12-22. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate Cancer [Phase 1]

See pricing